Angéle Schoenfelder

Title: Angéle Schoenfelder: Innovator in Neuropsychological Treatments

Introduction

Angéle Schoenfelder is a notable inventor based in Lampertheim, France. He has made significant contributions to the field of neuropsychology through his innovative research and development of pharmaceutical compounds. His work focuses on addressing neuropsychological disorders, which are critical areas of study in modern medicine.

Latest Patents

Schoenfelder holds a patent for "3,4-dihydro-2-naphthamide derivatives as selective dopamine D3 ligands." This invention relates to 3,4-dihydro-2-naphthamide derivatives of a specific formula, which are utilized in pharmaceutical compositions. These compounds serve as partial agonists or antagonists of the dopamine D3 receptor, offering potential therapeutic applications for treating various neuropsychological disorders. He has 1 patent to his name.

Career Highlights

Angéle Schoenfelder is affiliated with the Institut National de la Santé et de la Recherche Médicale, a prestigious research institution in France. His work at this institution has allowed him to explore innovative solutions for complex medical challenges. His research has contributed to the understanding and treatment of neuropsychological conditions, showcasing his commitment to advancing medical science.

Collaborations

Schoenfelder has collaborated with esteemed colleagues, including Pierre Sokoloff and Catherine Pilon. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research efforts.

Conclusion

Angéle Schoenfelder's contributions to the field of neuropsychology through his innovative patents and collaborative work highlight his importance as an inventor. His dedication to developing effective treatments for neuropsychological disorders continues to make a significant impact in the medical community.